BRIEF published on 07/09/2024 at 09:10, 1 year 8 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization Drug Development Pharmaceutical Market Master Services Agreement BioNxt Solutions Cladribine ODF
BRIEF published on 07/09/2024 at 09:10, 1 year 8 months ago BioNxt signe un accord-cadre de services avec une organisation internationale de recherche, de développement et de fabrication sous contrat Marché Pharmaceutique Développement De Médicaments Solutions BioNxt Cladribine ODF Contrat-cadre De Services
PRESS RELEASE published on 07/09/2024 at 09:05, 1 year 8 months ago BioNxt Signs Master Services Agreement with International Contract Research, Development, and Manufacturing Organization BioNxt Solutions Inc. signs master services agreement with German-based CRDMO for product development of oral dissolvable drug formulations BioNxt Solutions Inc. Product Development Master Services Agreement CRDMO Oral Dissolvable Drug Formulations
BRIEF published on 06/20/2024 at 01:05, 1 year 9 months ago BioNxt Solutions Closes Second Tranche of Private Placement Private Placement Common Shares Warrants Research Funding BioNxt Solutions
BRIEF published on 06/20/2024 at 01:05, 1 year 9 months ago BioNxt Solutions clôture la deuxième tranche de placement privé Placement Privé Actions Ordinaires Bons De Souscription Financement De La Recherche Solutions BioNxt
PRESS RELEASE published on 06/20/2024 at 01:00, 1 year 9 months ago BioNxt Solutions Announces Closing of Second Tranche of Non-Brokered Private Placement BioNxt Solutions Inc. closes the second tranche of non-brokered private placement, raising $270,000. Proceeds will fund research, development, and working capital Private Placement Common Shares Working Capital Research And Development BioNxt Solutions Inc.
BRIEF published on 04/26/2024 at 05:55, 1 year 10 months ago BioNxt Solutions Advances Cladribine Studies and Announces Financing Initiative Private Placement BioNxt Solutions Inc. Multiple Sclerosis Cladribine Program Pharmaceutical Development
BRIEF published on 04/26/2024 at 05:55, 1 year 10 months ago BioNxt Solutions fait progresser les études sur la cladribine et annonce une initiative de financement Placement Privé BioNxt Solutions Inc. Sclérose En Plaques Programme Cladribine Développement Pharmaceutique
PRESS RELEASE published on 04/26/2024 at 05:50, 1 year 10 months ago Bionxt Solutions Announces Odf Cladribine Update and Financing BioNxt Solutions Inc. advances Cladribine program to human bioavailability studies in Europe, targeting MS market. Announces private placement for research and development Private Placement BioNxt Solutions Inc. Cladribine Program Bioavailability Studies Multiple Sclerosis Market
BRIEF published on 03/18/2024 at 08:10, 2 years ago BioNxt Advances Towards Human Trials with ODF Cladribine for MS Clinical Trials BioNxt Solutions Inc. Multiple Sclerosis Drug Delivery Technology Pharmaceutical Market
Published on 03/24/2026 at 18:55, 1 hour 13 minutes ago Norse Gold Announces Closing of Private Placement Financing and Pending Reactivation on the TSX-V
Published on 03/24/2026 at 13:30, 6 hours 38 minutes ago GGL Resources Corp. Announces Closing of Earn-In Agreement with Nelson Resources Limited on Its Gold Point High-Grade Gold-Silver Project, Nevada
Published on 03/24/2026 at 13:30, 6 hours 38 minutes ago Innodata Announces Date of Annual Shareholder Meeting
Published on 03/24/2026 at 12:35, 7 hours 33 minutes ago Silver X Acquires the High-Grade Pampas Gold-Silver Project, Expanding its Precious Metal Asset Base in Peru
Published on 03/24/2026 at 12:33, 7 hours 35 minutes ago Mako Mining Completes Acquisition of Mt. Hamilton in Nevada
Published on 03/24/2026 at 19:49, 18 minutes ago EEII AG: Cancellation of the Extraordinary General Meeting of March 26, 2026
Published on 03/24/2026 at 19:41, 26 minutes ago ASMALLWORLD Honoured with Regional Virtuoso Award in Continental Europe for “Most Engaged Member” in Recognition of Their Exceptional Contribution
Published on 03/24/2026 at 19:05, 1 hour 3 minutes ago WBS Power Advances 3.2 GW Energy Infrastructure for Hyperscale Data Center Campus
Published on 03/24/2026 at 18:39, 1 hour 28 minutes ago EQS-Adhoc: FORTEC Elektronik Aktiengesellschaft: Adjustment of the earnings forecast for the financial year 2025/2026
Published on 03/24/2026 at 18:00, 2 hours 8 minutes ago Cham Swiss Properties places bond of CHF 100 million
Published on 03/24/2026 at 17:46, 2 hours 21 minutes ago NRJ GROUP - Press release annual results 2025
